Onconext Risk BRCA

OncoNext® Risk BRCA includes sequencing of BRCA1 and BRCA2 genes using the NGS method and mutation analysis to assess the patient's genetic predisposition to breast and ovarian cancer. BRCA1 and BRCA2 genes are the main genes responsible for hereditary predisposition to these pathologies. The aim of this study is to identify individuals who may have a higher genetic risk of developing hereditary oncological diseases.

Recommendation for when to perform the test: recommended for those at risk of cancer or those wishing to perform a preventive test.

Sample: blood.

Execution time after reaching the laboratory: 15 - 25 business days.